Guizhou Yibai Pharmaceutical Co., Ltd. (SHA:600594)

China flag China · Delayed Price · Currency is CNY
3.990
-0.040 (-0.99%)
Mar 11, 2026, 2:14 PM CST
13.35%
Market Cap 3.16B
Revenue (ttm) 1.91B
Net Income (ttm) -234.63M
Shares Out 784.39M
EPS (ttm) -0.30
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 5,739,800
Average Volume 12,057,574
Open 4.050
Previous Close 4.030
Day's Range 3.980 - 4.050
52-Week Range 2.940 - 4.920
Beta 0.30
RSI 49.02
Earnings Date Apr 23, 2026

About SHA:600594

Guizhou Yibai Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China. It offers products in the form of capsules, tablets, granules, syrups, small-volume injections, freeze-dried powder injections, lyophilized powder injections, pills, and oral solutions in the areas of tumor system, cerebrovascular, respiratory system, rheumatic bone, digestive system, pediatric, anti-infection, anti-inflammatory, analgesic, cancer, orthopedics, digestion, andrology, and urology. The company also engages in investme... [Read more]

Sector Healthcare
Founded 1995
Employees 5,261
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600594
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.